TG Therapeutics Inc (TGTX)

Days of sales outstanding (DSO)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Receivables turnover 2.55 2.27 4.07 4.31 4.35 4.60 1.08 0.73 — — 79.10 8.76 4.82 3.18 2.59 1.18 — — — —
DSO days 143.32 161.00 89.60 84.63 83.87 79.34 338.10 497.14 — — 4.61 41.66 75.79 114.65 140.77 310.27 — — — —

December 31, 2024 calculation

DSO = 365 ÷ Receivables turnover
= 365 ÷ 2.55
= 143.32

The days of sales outstanding (DSO) is a financial ratio that indicates the average number of days it takes for a company to collect payments from its customers.

Analyzing the DSO trend of TG Therapeutics Inc over the available periods shows a fluctuating pattern.

- As of March 31, 2021, the DSO was relatively high at 310.27 days, indicating a prolonged time for the company to collect payments from customers.
- However, there was a significant improvement by June 30, 2022, where the DSO decreased to 4.61 days, suggesting a more efficient collection process.
- The DSO metric increased again to 497.14 days by March 31, 2023, signifying a regression in the collection efficiency.
- This trend was followed by a notable decline in DSO to 84.63 days by March 31, 2024, indicating an improvement in the accounts receivable collection process.

Overall, while there have been fluctuations in DSO over the periods analyzed, it is crucial for TG Therapeutics Inc to consistently monitor and manage its DSO to ensure efficient cash flow management and healthy liquidity position.